Funder: National Institutes of Health (NIH)

Due Dates: September 29, 2025 | January 28, 2026 | May 28, 2026 | September 28, 2026 | January 28, 2027 | May 28, 2027 | September 28, 2027 | January 28, 2028

Funding Amounts: No budget cap; project periods: UG3 up to 4 years, UH3 up to 4 years, total max 5 years; budgets must be justified by project needs.

Summary: Supports translational activities and clinical studies for medical devices to prevent, monitor, diagnose, or treat nervous system disorders, accelerating device development toward first-in-human studies.

Key Information: Milestone-driven UG3/UH3 cooperative agreement; strict application requirements and required pre-application consultation with NIH recommended.